We are live on ! Find out more
THRD

Third Harmonic Bio
THRD

Delisted

THRD was delisted on the 30th of July, 2025.

Back to rankings

84 hedge funds and large institutions have $597M invested in Third Harmonic Bio in 2024 Q3 according to their latest regulatory filings, with 14 funds opening new positions, 36 increasing their positions, 18 reducing their positions, and 6 closing their positions.

New
Increased
Maintained
Reduced
Closed

133% more first-time investments, than exits

New positions opened: 14 | Existing positions closed: 6

100% more repeat investments, than reductions

Existing positions increased: 36 | Existing positions reduced: 18

14% more capital invested

Capital invested by funds: $523M → $597M (+$73.4M)

11% more funds holding

Funds holding: 76 → 84 (+8)

8.85% more ownership

Funds ownership: 98.28% → 107.12% (+8.8%)

0% more funds holding in top 10

Funds holding in top 10: 1 → 1 (0)

Holders
84
Holders Change
+8
Holders Change %
+10.53%
% of All Funds
1.21%
Holding in Top 10
1
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.01%
New
14
Increased
36
Reduced
18
Closed
6
Calls
$96K
Puts
–
Net Calls
+$96K
Net Calls Change
-$22K

Top Buyers

1
TCM
TCG Crossover Management
California
+$29.9M
2
T. Rowe Price Investment Management
T. Rowe Price Investment Management
Maryland
+$18.3M
3
Point72 Asset Management
Point72 Asset Management
Connecticut
+$3.96M
4
Fidelity Investments
Fidelity Investments
Massachusetts
+$3.77M
5
WP
Woodline Partners
California
+$1.54M

Top Sellers

1
RCM
RA Capital Management
Massachusetts
-$9.32M
2
CC
Commodore Capital
New York
-$2.29M
3
SCM
Sio Capital Management
New York
-$2.12M
4
SSA
Schonfeld Strategic Advisors
New York
-$916K
5
Citadel Advisors
Citadel Advisors
Florida
-$899K
Name Holding Trade Value Shares
Change 		Change in
Stake
AVLSA
1
Atlas Venture Life Science Advisors
Massachusetts
$148M – – –
O
2
OrbiMed
New York
$78.3M – – –
BI
3
BVF Inc
California
$59.2M – – –
EC
4
EcoR1 Capital
California
$43.1M – – –
GA
5
General Atlantic
New York
$40.1M – – –
T. Rowe Price Investment Management
6
T. Rowe Price Investment Management
Maryland
$38.4M +$18.3M +1,481,014 +110%
TCM
7
TCG Crossover Management
California
$32.7M +$29.9M +2,415,000 New
BC
8
Boxer Capital
California
$27.1M – – –
BlackRock
9
BlackRock
New York
$19.8M +$374K +30,169 +2%
CC
10
Commodore Capital
New York
$18.4M -$2.29M -184,857 -12%
RCM
11
RA Capital Management
Massachusetts
$17.4M -$9.32M -752,230 -37%
Vanguard Group
12
Vanguard Group
Pennsylvania
$12.1M +$221K +17,853 +2%
Citadel Advisors
13
Citadel Advisors
Florida
$8.24M -$899K -72,595 -11%
Geode Capital Management
14
Geode Capital Management
Massachusetts
$5.97M +$97.2K +7,845 +2%
State Street
15
State Street
Massachusetts
$5.43M +$182K +14,662 +4%
Point72 Asset Management
16
Point72 Asset Management
Connecticut
$4.33M +$3.96M +319,329 New
Fidelity Investments
17
Fidelity Investments
Massachusetts
$4.17M +$3.77M +304,250 +8,133%
Invesco
18
Invesco
Georgia
$3.59M -$72.5K -5,855 -2%
SSA
19
Schonfeld Strategic Advisors
New York
$3.47M -$916K -73,948 -22%
PHP
20
Parkman Healthcare Partners
Connecticut
$3.22M +$1.29M +104,495 +78%
Northern Trust
21
Northern Trust
Illinois
$2.59M +$489K +39,471 +26%
Morgan Stanley
22
Morgan Stanley
New York
$2.2M +$432K +34,849 +27%
Charles Schwab
23
Charles Schwab
California
$1.93M +$63.5K +5,126 +4%
WP
24
Woodline Partners
California
$1.68M +$1.54M +123,923 New
Renaissance Technologies
25
Renaissance Technologies
New York
$1.42M -$68.6K -5,540 -5%
1
2 3 4

THRD Hedge Fund Activity: Q3 2024 in Review

84 of the 6,964 institutional investors tracked by Wall St. Rank reported a position in Third Harmonic Bio (THRD) for Q3 2024, worth a combined $597M — up 14% from $523M a quarter earlier.

Buyers outnumbered sellers: 14 funds opened new THRD positions and 6 closed out — a net gain of 8 holders — while 36 added to existing stakes and 18 trimmed.

The largest buyer was TCG Crossover Management, opening a new position worth an estimated $29.9M. The largest seller was RA Capital Management, cutting an estimated $9.32M.

  • 84 institutional investors held Third Harmonic Bio (THRD) as of Q3 2024, up from 76 in Q2 2024.
  • Funds reported $597M of Third Harmonic Bio stock for Q3 2024, up 14% quarter-over-quarter.
  • 14 funds opened new Third Harmonic Bio positions in Q3 2024 and 6 closed out, a net change of +8 holders.
  • The largest Third Harmonic Bio buyer in Q3 2024 was TCG Crossover Management, an estimated $29.9M added.
  • The largest Third Harmonic Bio seller in Q3 2024 was RA Capital Management, an estimated $9.32M sold.

Based on aggregated 13F filings for Q3 2024.